Results 161 to 170 of about 12,776,407 (326)

Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism

, 1998
In this review, we analyze data from randomized trials in which low molecular weight heparin was compared with unfractionated heparin, both to estimate the treatment effect of low molecular weight heparin in the initial treatment of venous ...
Lensing, A. W., Hettiarachchi, R. J., Prins, M. H., Buller, H. R.   +3 more
core  

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.

New England Journal of Medicine, 1997
G. Simonneau, H. Sors, B. Charbonnier, Y. Page, J. Laaban, R. Azarian, M. Laurent, J. Hirsch, E. Ferrari, J. Bosson, D. Mottier, B. Beau   +11 more
semanticscholar   +1 more source

Innovation of plant‐derived extracellular vesicles and interdisciplinary research: From discovery to biomedical applications

BMEMat, EarlyView.
Plant‐derived extracellular vesicles offer numerous advantages and are regarded as highly promising candidates in the field of biomedicine. Abstract Extracellular vesicles (EVs) are double‐membrane vesicular structures that can be secreted by nearly all living cells.
Zilin Li, Yi Wei, Ben Hu, Yafang Song, Xiaojia Chen, Nik Ahmad Nizam Nik Malek, Tongkai Chen   +6 more
wiley   +1 more source

Revisiting low-molecular-weight heparin for venous thromboembolism: from pharmacology to precision dosing and implementation. [PDF]

Front Pharmacol
Zhu S, Ni Q, He J.
europepmc   +1 more source

Engineering programmable peptide hydrogels for chronic refractory wounds: A mechanism‐driven framework

BMEMat, EarlyView.
To break the self‐perpetuating pathology of chronic wounds, we propose a mechanism‐driven engineering framework for peptide‐based hydrogels. This review elucidates a hierarchical strategy—from molecular design to intelligent, multi‐functional systems—that enables these programmable biomaterials to dynamically intervene in key pathological loops and ...
Xiaoyu Lv, Xinyi Chao, Jiamin Zhang, Jianfeng Liu   +3 more
wiley   +1 more source

During pregnancy, anticoagulant effect of low molecular weight heparin can be determined with both thrombelastography and anti-factor Xa activity, or not? [PDF]

Anaesth Intensive Care
Carlberg N, Olsson A, Hellgren M, Karlsson O.   +3 more
europepmc   +1 more source

Small scale purification and biophysical characterization of haptoglobin derived from human Cohn fraction IV

Biotechnology Progress, EarlyView.
Abstract Haptoglobin (Hp) is a polymorphic acute phase α‐2 glycoprotein found in plasma that plays a critical role in binding, neutralizing, and removing cell‐free hemoglobin (Hb) from the circulation. Under clinical conditions characterized by high levels of hemolysis, such as in patients with sickle cell disease (SCD), large quantities of cell‐free ...
Shuwei Lu, Mohd Asim Khan, Pedro Cabrales, David C. Irwin, Paul W. Buehler, Andre F. Palmer   +5 more
wiley   +1 more source

Low-molecular-weight heparin in patients with renal insufficiency

Swiss Medical Weekly, 2009
AG Fischer
doaj   +1 more source

Assessment of Anti-Factor Xa Levels in Children Receiving Low-Molecular-Weight Heparin for Treatment and Prophylaxis. [PDF]

Children (Basel)
Panova M, Spasova M, Stoencheva S, Dimcheva T, Sotkova-Ivanova I, Boykova P.   +5 more
europepmc   +1 more source

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

New England Journal of Medicine, 1996
W. Geerts, R. Jay, K. Code, Erluo Chen, J. Szalai, E. Saibil, P. Hamilton   +6 more
semanticscholar   +1 more source